Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2026-02-21 @ 3:03 AM
Study NCT ID:
NCT07060794
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-11
First Post:
2025-07-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafenoquine and DHA-piperaquine (TADORE- Plus)
Sponsor:
Menzies School of Health Research
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TADORE+
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None